EUVIMEDEUVIMED entdecken
Crossref

Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease

Huai Wang iD, Qianxi Yang iD, Chuanhua Ge, Jiaqi Liu, Hemant Mistry iD, Yun-Fang Jia iD, Guiqiong He

Journal of Alzheimer’s Disease · 2025-09 · 107 (2) · 542-560

DOI: 10.1177/13872877251361042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025-09. Verfasst von Huai Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, Alzheimer Disease, tau Proteins, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is a progressive neurodegenerative disorder driven by complex, incompletely understood genetic and pathogenic factors. E3 ubiquitin ligases (E3s), crucial for protein degradation, are implicated in AD, but their specific contributions to its progression remain to be elucidated.

Objective

This study aimed to identify dysregulated E3s in AD and elucidate the role of a hub E3, FBXW7, in its pathogenesis and tau protein regulation.

Methods

We integrated four datasets to identify differentially expressed E3s (DE-E3s) in AD and performed functional enrichment and PPI network analyses. Machine learning identified hub E3s and stratified AD patients into molecular subtypes. Furthermore, we validated the expression and functional role of FBXW7 using western blot, immunoprecipitation-mass spectrometry (IP-MS), and co-immunoprecipitation (Co-IP).

Results

We identified 42 DE-E3s primarily enriched in protein ubiquitination and Notch signaling pathways. FBXW7 and ENC1 emerged as hub E3s, stratifying patients into two subtypes. Subtype I exhibited enrichment of inflammatory pathways, suggesting immune dysregulation. Conversely, subtype II displayed activation of pathways associated with synaptic dysfunction and neuronal loss, potentially representing distinct primary pathological features. Furthermore, we observed decreased FBXW7 expression in AD models compared to controls. Notably, FBXW7 interacted with Tau protein. Overexpression of FBXW7 reduced the levels of both total Tau and p-Tau Ser262, and this reduction in Tau levels was reversed by MG132 treatment.

Conclusions

This study comprehensively identified E3s associated with AD, with our findings highlighting FBXW7 as a potential key regulator of AD pathogenesis through its modulation of tau protein levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

F-Box-WD Repeat-Containing Protein 7Alzheimer Diseasetau ProteinsTranscriptomeHumansProteomicsHomeostasisMaleAnimalsMiceFemale

Stichwörter der Autor:innen

Alzheimer's diseaseE3 ubiquitin ligaseFBXW7machine learningmolecular subtypetau

Substanzen

F-Box-WD Repeat-Containing Protein 7tau ProteinsFBXW7 protein, humanMAPT protein, human

Autor:innen und Institutionen

  • Center for Neuroscience, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • Department of Anatomy, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • Leicester Medical School, University of Leicester, Leicester, UK.
  • Department of Physiology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.
  • Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing, China.

ORCID-Profile: Huai Wang, Qianxi Yang, Hemant Mistry, Yun-Fang Jia

Zitieren

APA

Wang, H., Yang, Q., Ge, C., Liu, J., Mistry, H., Jia, Y. F., & He, G. (2025). Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease. Journal of Alzheimer’s Disease, 107(2), 542-560. https://doi.org/10.1177/13872877251361042

Vancouver

Wang H, Yang Q, Ge C, Liu J, Mistry H, Jia YF, et al. Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease. Journal of Alzheimer’s Disease. 2025;107(2):542-560. doi:10.1177/13872877251361042

BibTeX
@article{Wang2025,
  author = {Wang, Huai and Yang, Qianxi and Ge, Chuanhua and Liu, Jiaqi and Mistry, Hemant and Jia, Yun-Fang and He, Guiqiong},
  title = {Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  volume = {107},
  number = {2},
  pages = {542--560},
  doi = {10.1177/13872877251361042}
}
Kostenlos starten →